MSB 3.21% $1.13 mesoblast limited

Ann: MSB Presents Commercial Plans at 2020 Biotech Showcase, page-41

  1. 195 Posts.
    lightbulb Created with Sketch. 16
    Liked your post. But I am curious as to why the company would think that keeping positive results info confidential would benefit shareholders. Surely a better bargaining position could be established if the market knew those results? If not, the any potential purchaser/licensee/acquirer could steal a match.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.